secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2026-08-05T20:17:48+00:00
Accession:  0001964738-26-000045
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum Q2 sales up 9.5% organic; adj. EPS $2.55 (+50.9%); plans to separate HIS segment
--------------------------------------------------------------------------------

- Sales $2.2B, organic +9.5%; GAAP EPS $0.53, adjusted EPS $2.55 (+50.9% YoY).
- Operating cash flow $227M, free cash flow $144M (+144% YoY).
- Announces intent to separate Health Information Systems business segment.
- Raises full-year 2026 guidance for organic sales growth, adjusted EPS, and free cash flow.
- CEO Bryan Hanson cites strong execution and transformation progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/0001964738-26-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/solv-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001964738-26-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer